HEALTH SERVICES KENTUCKY CABINET FOR: $113M Department of Health and Human Services Grant
Summary
This $113M grant to the Kentucky Cabinet for Health and Family Services funds the state's opioid and stimulant overdose response effort. As the recipient is a state government entity, no publicly traded company is directly impacted, though the broader healthcare sector may see indirect benefits from sustained federal investment in substance abuse treatment infrastructure.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The $113M grant is a non-commercial award to a state government, not a public company.
- 2.Federal opioid response spending continues but with no direct public equity beneficiaries from this specific award.
- 3.Investors should monitor broader legislative trends (e.g., SAMHSA appropriations) rather than this single contract for sector signals.
Market Implications
This contract has negligible direct market implications. The $113M award flows to state government operations and subcontractors that are not publicly listed. The healthcare sector may see a mild, diffuse tailwind from sustained federal spending on addiction treatment, but no specific ticker moves are attributable. Investors should look for contracts where public companies are named recipients or prime contractors to capture revenue impact.
Full Analysis
The contract is a project grant awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) to the Kentucky Cabinet for Health and Family Services. The $113M award supports the Kentucky Overdose Response Effort (KORE) over three years, focusing on evidence-based prevention, treatment, and recovery services for opioid and stimulant use disorders. The state agency is not a publicly traded entity, so no direct stock market impact exists from this award. However, the contract reflects ongoing federal prioritization of the opioid crisis, which sustains demand for related healthcare services and pharmaceuticals, such as medications for opioid use disorder (MOUD). Companies like Indivior ($INDV) or Alkermes ($ALKS) that manufacture addiction treatments could see downstream benefits, but the contract does not name them as subcontractors. No related bills in the provided list directly connect to this opioid response funding, so legislative tailwinds are absent. The grant is purely a state-level operational funding stream, not a procurement contract, meaning it does not generate direct revenue for public companies. The impact on financial markets is minimal and indirect.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
GEORGIA EMERGENCY MANAGEMENT AND HOMELAND SECURITY AGENCY: $1.6B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
NORTH CAROLINA DEPARTMENT OF PUBLIC SAFETY: $2.4B Department of Homeland Security Grant
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.0B Department of Health and Human Services Grant
DEPARTMENT OF SOCIAL SERVICES CONNECTICUT: $6.9B Department of Health and Human Services Grant
STATE OF COLORADO - DEPT OF HEALTH CARE POLICY & FINANCING: $9.2B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Ending Birth Tourism
This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.
Contract Details
Recipient
HEALTH SERVICES KENTUCKY CABINET FOR
Award Amount
$112,972,692
Awarding Agency
Department of Health and Human Services
Sub-Agency
Substance Abuse and Mental Health Services Administration
Contract Type
PROJECT GRANT (B)
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →